Prediction of immune infiltration and prognosis for patients with gastric cancer based on the immune-related genes signature
Open Access
- 22 November 2023
- Vol. 9 (12) , e22433
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China (82172645)
- Bethune Charitable Foundation
This publication has 35 references indexed in Scilit:
- Identification of a prognostic 28-gene expression signature for gastric cancer with lymphatic metastasisBioscience Reports, 2019
- Novel immune–risk score of gastric cancer: A molecular prediction model combining the value of immune–risk status and chemosensitivityCancer Medicine, 2019
- ImmPort, toward repurposing of open access immunological assay data for translational and clinical researchScientific Data, 2018
- TGFβ drives immune evasion in genetically reconstituted colon cancer metastasisNature, 2018
- Metabolic Interactions in the Tumor MicroenvironmentTrends in Cell Biology, 2017
- Development and Validation of an Individualized Immune Prognostic Signature in Early-Stage Nonsquamous Non–Small Cell Lung CancerJAMA Oncology, 2017
- clusterProfiler: an R Package for Comparing Biological Themes Among Gene ClustersOMICS: A Journal of Integrative Biology, 2012
- Cancer immunotherapy comes of ageNature, 2011
- S-1 plus cisplatin versus S-1 alone for first-line treatment of advanced gastric cancer (SPIRITS trial): a phase III trialThe Lancet Oncology, 2008
- p53 target gene AEN is a nuclear exonuclease required for p53-dependent apoptosisOncogene, 2008